Cholinergic dysfunctions and enhanced oxidative stress in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats.

Neurotoxicity Research
Reyaz W AnsariVinay K Khanna

Abstract

This study is focused on understanding the mechanism of neurobehavioral toxicity of lambda-cyhalothrin, a new generation type II synthetic pyrethroid in developing rats following their exposure from post-lactational day (PLD)22 to PLD49 and investigate whether neurobehavioral alterations are transient or persistent. Post-lactational exposure to lambda-cyhalothrin (1.0 or 3.0 mg/kg body weight, p.o.) affected grip strength and learning activity in rats on PLD50 and the persistent impairment of grip strength and learning was observed at 15 days after withdrawal of exposure on PLD65. A decrease in the binding of muscarinic-cholinergic receptors in frontocortical, hippocampal, and cerebellar membranes associated with decreased expression of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) in hippocampus was observed following exposure to lambda-cyhalothrin on PLD50 and PLD65. Exposure to lambda-cyhalothrin was also found to increase the expression of growth-associated protein-43 in hippocampus of rats on PLD50 and PLD65 as compared to controls. A significant increase in lipid peroxidation and protein carbonyl levels and decreased levels of reduced glutathione and activity of superoxide dismutase, catalase, and gluta...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jan 1, 1990·Methods in Enzymology·R L LevineE R Stadtman
Sep 21, 1990·Biochimica Et Biophysica Acta·F MichelangeliA G Lee
Jan 1, 1989·Journal of Toxicology and Environmental Health·M Farage-Elawar
Dec 1, 1989·Ophthalmic Paediatrics and Genetics·C W Storimans, M J Van Schooneveld
Feb 1, 1989·Pharmacology, Biochemistry, and Behavior·J M Wehner, M Upchurch
Jan 1, 1984·Methods in Enzymology·L Flohé, W A Günzler
Sep 1, 1994·Journal of Applied Toxicology : JAT·V K KhannaP K Seth
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·M J ForsterR S Sohal
Jul 1, 1996·Pharmacology & Toxicology·T Narahashi
Feb 1, 1997·Trends in Neurosciences·L I Benowitz, A Routtenberg
May 20, 1998·Pharmacology, Biochemistry, and Behavior·S Sarin, K D Gill
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·A RouttenbergU Namgung
May 29, 2001·Current Medicinal Chemistry·L M SayreG Perry
Nov 17, 2001·Neurotoxicology and Teratology·E G MoreiraV S Vassilieff
Jan 29, 2002·Toxicology·David M SoderlundMyra L Weiner
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·A V TerryM A Prendergast
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ruolan LiuMichel Baudry
Sep 2, 2003·Mutation Research·Ayla CelikUlkü Cömelekoglu
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Nov 1, 1963·The Journal of Cell Biology·W L STAHLR E BASFORD
Dec 6, 2003·Human & Experimental Toxicology·W D RatnasooriyaY N A Jayatunga
Aug 4, 2004·Neurotoxicology·Muhammad Mubarak HossainHaruo Kobayashi
Aug 10, 2004·Nature Medicine·Julie K Andersen
Feb 3, 2005·Environmental Health Perspectives·Timothy J ShaferKevin M Crofton
Mar 8, 2005·Toxicology and Industrial Health·María R Martinez-LarrañagaMaría J Díaz
Apr 9, 2005·Ecotoxicology and Environmental Safety·Ayla CelikAli Aşkin
Apr 21, 2005·Environmental Toxicology and Chemistry·Erin L AmwegNicole M Ureda
Jul 13, 2005·Environmental Research·Muhammad Ilyas TariqIshtiaq Hussain
Sep 27, 2005·Toxicological Reviews·Sally M BradberryJ Allister Vale
Oct 14, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·M J WolanskyK M Crofton
Dec 6, 2005·Pharmacology & Therapeutics·David E Ray, Jeffrey R Fry
Dec 6, 2005·Archives of Environmental Contamination and Toxicology·P AmoahW J Ntow
Feb 3, 2006·Environmental Health Perspectives·Terry P BrownLeonard S Levy
Mar 30, 2006·Environmental Science & Technology·Erin L AmwegMichael J Lydy
Jun 30, 2006·Journal of Neurochemistry·Barry Halliwell
Aug 11, 2006·Pest Management Science·Sharon P LawlerAnthony J Cornel
Sep 8, 2006·Toxicology and Applied Pharmacology·Muhammad Mubarak HossainHaruo Kobayashi

❮ Previous
Next ❯

Citations

May 12, 2004·Consciousness and Cognition·L Andrew Coward, Ron Sun
Sep 28, 2012·Nutrients·Van Anh NguyenSuzanne M de la Monte
Feb 13, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Lalit P ChandravanshiVinay K Khanna
Mar 5, 2014·Molecular Neurobiology·Rajesh Singh Yadav, Neeraj Kumar Tiwari
Feb 3, 2016·Journal of Alzheimer's Disease : JAD·Ming TongSuzanne M de la Monte
Nov 8, 2016·Toxicology Mechanisms and Methods·Chunlei YuYingcai Niu
Dec 3, 2016·Environment International·Yael Abreu-Villaça, Edward D Levin
Oct 16, 2015·Environmental Toxicology·Farah SyedInderpal Soni
Aug 10, 2018·Toxicology Research·Farah SyedInderpal Soni
Aug 21, 2019·Frontiers in Microbiology·Pankaj BhattShaohua Chen
Feb 23, 2021·EFSA Journal·UNKNOWN European Food Safety Authority (EFSA)Luc Mohimont
Apr 7, 2021·Critical Reviews in Toxicology·Anandha Rao Ravula, Suresh Yenugu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved